Nivolumab Antibody
Nivolumab is a humanized monoclonal antibody targeting PD-1, utilized for its anti-tumor activity in research on melanoma, non-small cell lung cancer, and renal cell carcinoma. It is widely applied in both in vitro assays and in vivo models to investigate immune checkpoint blockade mechanisms and therapeutic efficacy.
Product Specifications
Product Name Alternative
Nivolumab, PD1, PD-1, PD-1/PD-L1, PD1/PDL1, PD-L1, PDL1
Target
PD-1/PD-L1
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation
Concentration
10.2 mg/mL
Purity
98.00% (May vary between batches)
Molecular Weight
143.62 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6251674-01 0.1 mL
CD88 (CD88 Antigen, Anaphylatoxin Receptor, C5a Anaphylatoxin Chemotactic Receptor, C5aR, C5a-R, C5a Ligand, C5R1) (PE)
Sign In for Pricing
View Details MBS6251674-02 5x 0.1 mL
CD88 (CD88 Antigen, Anaphylatoxin Receptor, C5a Anaphylatoxin Chemotactic Receptor, C5aR, C5a-R, C5a Ligand, C5R1) (PE)
Sign In for Pricing
View Details